Biogen, Inc. (BIIB)
196.38
+4.35
(+2.27%)
USD |
NASDAQ |
Feb 23, 16:00
196.28
-0.10
(-0.05%)
After-Hours: 18:22
Biogen Research and Development Expense (Quarterly) : 434.00M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.802B |
| Merck & Co., Inc. | 3.992B |
| AbbVie, Inc. | 2.579B |
| Pfizer Inc. | 3.206B |
| Stoke Therapeutics, Inc. | 37.25M |